2024 ASCO® Annual Meeting Insights Hub

Meeting coverage & Vumedi’s exclusive highlights, all in one place.

 

2024 ASCO® Annual Meeting Insights Hub
C

ASCO® 2024 Insights: "CHAARTED2 Trial - Cabazitaxel + Abiraterone vs. Abiraterone Alone Post-Docetaxel for mCRPC"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Christos Kyriakopoulos
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Christos Kyriakopoulos
347 views
June 12, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira

Featured Video

06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy
GU
06:02
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Landscape Analysis & Oncologic Outcom…

Feat. T. Stewart
21:54
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Prostate Cancer Take-Home Messages

Feat. E. Efstathiou
10:19
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Current Updates in RCC - Clinical Implicat…

Feat. K. Mittal
15:28
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Bladder and RCC Highlights"

Feat. K. Tawagi, N. Reizine
34:26
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Prostate Cancer Highlights"

Feat. N. Reizine, K. Tawagi
22:27
2024 ASCO® Annual Meeting Insights Hub

Developmental Therapeutics Highlights From ASCO® 2024

Feat. G. Sonpavde
20:41
2024 ASCO® Annual Meeting Insights Hub

Bladder Cancer Highlights From ASCO® 2024

Feat. G. Sonpavde
09:00
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "CHAARTED2 Trial - Cabazitaxel + Abiratero…

Feat. C. Kyriakopoulos
19:41
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "A Clinical-Genetic ctDNA-Based Prognostic…

Feat. S. Halabi
06:58
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Systemic Treatments in Favorable and Very…

Feat. M. Zarba
07:29
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "MAST Study - Metformin in Reducing Progre…

Feat. N. Fleshner
07:26
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "TRANSFORMER Trial - Blood-Based Markers o…

Feat. E. Antonarakis
13:33
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Impact of Exposure on Outcomes With Enfor…

Feat. D. Petrylak
15:57
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Treatment Strategies and QoL Impact in mCR…

Feat. C. Paller
19:49
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Advances in RCC and Urothelial Carcinoma -…

Feat. C. Porta
17:44
ecancer

ASCO® 2024 Summary: "Expert Panel Discussion on the Real World …

Feat. F. Schlürmann, B. Hadaschik, K. Fizazi
22:22
ecancer

ASCO® 2024 Summary: "Expert Panel Discussion on Best Practices …

Feat. M. Schostak, A. Wyatt, C. Ryan, E. Antonarakis
05:44
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "KEYNOTE-426 Trial - Biomarker Analysis of…

Feat. B. Rini
08:55
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Organ Preserving and Reconstructive Surge…

Feat. A. Burnett
09:15
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "CYCLONE 2 Study - Abemaciclib + Abiratero…

Feat. T. Todenhöfer
11:26
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Study EV-103 - Neoadjuvant Enfortumab Ved…

Feat. N. Mar
09:41
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "MANCAN2 Trial - Self-Help Cognitive Behav…

Feat. S. Crabb
04:41
ecancer

ASCO® 2024 Insights: "PSMAfore - HRQoL and Pain in Taxane-Naïve…

Feat. K. Fizazi
10:35
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "EMBARK Post Hoc Analysis of Sexual Activi…

Feat. S. Freedland
23:31
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Harnessing the Immune System in RCC - Cur…

Feat. D. Braun
09:35
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "EMBARK Study - Impact of Treatment Suspen…

Feat. S. Freedland
04:01
ecancer

ASCO® 2024 Insights: "CHAARTED2 Trial - Cabazitaxel With Abirat…

Feat. C. Kyriakopoulos
06:49
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Belzutifan for Advanced Renal Cell Carcin…

Feat. E. Jonasch
06:09
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Efficacy & Toxicity of 177Lu-PSMA-617…

Feat. V. Murthy
04:16
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "KEYNOTE-361 Trial - Quantitative ctDNA As…

Feat. T. Powles
05:28
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "ARV-766, a PROTAC Androgen Receptor Degra…

Feat. D. Petrylak
04:35
ecancer

ASCO® 2024 Insights: "SURE-01/02 Study - Perioperative Sacituzu…

Feat. A. Cigliola
06:27
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Evaluation of Persistence and Adherence f…

Feat. J. Hafron
09:54
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "1L Systemic Therapy Following Adjuvant IO…

Feat. T. El Zarif
05:33
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Lenvatinib + Pembro vs. Sunitinib in aRCC…

Feat. V. Grünwald
05:45
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Clinical Utility of Transcriptomic Signat…

Feat. Y. Chen
04:59
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "CORE-001 Study - Final Results of Cretost…

Feat. R. Li
05:39
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "ABBV-706 Study - Targeted ADC for Advance…

Feat. B. Garmezy
10:50
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "CA-62 - A New Biomarker for the Detection…

Feat. E. Klinski
06:42
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "AURA Trial Survival Data - Avelumab as Ne…

Feat. J. Blanc
06:52
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "HERCULES Trial - Pembro + Platinum-Based …

Feat. F. Maluf
13:42
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "KIM-1 Biomarker Analysis in IMmotion010 -…

Feat. L. Albiges
05:52
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "CheckMate 67T Trial - Safety & PROs o…

Feat. M. Bourlon
10:02
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "LITESPARK-013 Study Subgroup Analysis - B…

Feat. M. Atkins